Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emotion, Serotonin and Premenstrual Dysphoric Disorder (EmSeP)
2016-001217-25Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Premenstrual Dysphoric Disorder (PMDD) comparing Escitalopram arm with Placebo arm (2 arms). Primary endpoint: Neuropsychological and neuroimaging changes with escitalopram treatment. Started Jun 2016; status: completed.
02
Drugs
escitalopram
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on 2016-001217-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001217-25.